Myelopathy, Autoimmune/Paraneoplastic Evaluation, Spinal Fluid

If indirect immunofluorescence assay (IFA) pattern suggests anti-glial nuclear antibody (AGNA-1), then AGNA-1 immunoblot and AGNA-1 IFA titer will be performed at an additional charge.

If IFA pattern suggests amphiphysin antibody, then amphiphysin immunoblot and amphiphysin IFA titer will be performed at an additional charge.

If IFA pattern suggests anti-neuronal nuclear antibody type 1 (ANNA-1), then ANNA-1 immunoblot, ANNA-1 IFA titer, and ANNA-2 immunoblot will be performed at an additional charge.

If IFA pattern suggests ANNA-2 antibody, then ANNA-2 immunoblot, ANNA-2 IFA titer, and ANNA-1 immunoblot will be performed at an additional charge.

If client requests or the IFA pattern suggests ANNA-3 antibodies, then ANNA-3 IFA titer will be performed at an additional charge.

If IFA pattern suggests adaptor protein 3 beta 2 (AP3B2) antibodies, then AP3BC cell-binding assay (CBA) and AP3BC IFA titer will be performed at an additional charge.

If collapsin response-mediator protein 5 (CRMP-5)-IgG Western blot is positive, then CRMP-5-IgG IFA titer will be performed at an additional charge.

If IFA pattern suggests Purkinje cell cytoplasmic antibody type 1 (PCA-1), then PCA-1 immunoblot and PCA-1 IFA titer will be performed at an additional charge.

If IFA pattern suggests PCA-2 antibody, then PCA-2 IFA titer will be performed at an additional charge.

If IFA pattern suggests N-methyl-D-aspartate (NMDA) receptor antibody, then NMDA-receptor antibody CBA and NMDA-receptor antibody IFA titer will be performed at an additional charge.

If gamma-aminobutyric acid B (GABA-B) receptor antibody CBA is positive, then GABA-B-receptor antibody IFA titer will be performed at an additional charge.

If IFA pattern suggests dipeptidyl-peptidase-like protein-6 (DPPX) antibody, then DPPX antibody CBA and DPPX antibody IFA titer will be performed at an additional charge.

If IFA pattern suggests metabotropic glutamate receptor 1 (mGluR1) antibody, then mGluR1 antibody CBA and mGluR1 antibody IFA titer will be performed at an additional charge.

If IFA pattern suggests glial fibrillary acidic protein (GFAP) antibody, then GFAP antibody CBA and GFAP antibody IFA titer will be performed at an additional charge.

If the neuromyelitis optica/aquaporin-4-IgG (NMO/AQP4-IgG) fluorescence-activated cell sorting (FACS) screen assay requires further investigation, then NMO/AQP4-IgG FACS titration assay will be performed at an additional charge.

If IFA pattern suggests neuronal intermediate filament (NIF) antibody, then alpha internexin CBA, NIF heavy chain CBA, NIF light chain CBA, and NIF antibody IFA titer will be performed at an additional charge.

If IFA pattern suggests neurochondrin antibody, then neurochondrin antibody CBA and neurochondrin IFA titer will be performed at an additional charge.

If IFA pattern suggests septin 7 antibody, then septin 7 CBA and septin 7 IFA titer will be performed at an additional charge​.